We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Cardiff Oncology
CRDF
$64.3M
| $93.5K | ﹤0.01% |
+17,513
| New | +$46.5K |
|
3802
PUT
Ginkgo Bioworks
DNA
$481M
| $93.4K | ﹤0.01% |
+2,013
| New | +$104K |
|
3803
Clover Health Investments
CLOV
$2.28B
| $92.9K | ﹤0.01% |
117,023
-66,470
| -36% | -$60.5K |
|
3804
Gerdau
GGB
$9.44B
| $92.9K | ﹤0.01% |
25,211
-41,841
| -62% | -$151K |
|
3805
NatWest
NWG
$71.5B
| $92.9K | ﹤0.01% |
13,655
-51,375
| -79% | -$305K |
|
|
OSG
3806
DELISTED
Overseas Shipholding Group Inc.
OSG
| $92.7K | ﹤0.01% |
14,489
-49,961
| -78% | -$298K |
|
|
ITI
3807
DELISTED
Iteris, Inc.
ITI
| $92.7K | ﹤0.01% |
18,762
-44,938
| -71% | -$222K |
|
3808
CALL
Archer Aviation
ACHR
$3.64B
| $92.4K | ﹤0.01% |
+20,000
| New | +$100K |
|
|
OPTN
3809
DELISTED
OptiNose
OPTN
| $91.6K | ﹤0.01% |
+4,180
| New | +$92.8K |
|
|
DALN
3810
DELISTED
DallasNews
DALN
| $91.4K | ﹤0.01% |
23,939
+4,034
| +20% | +$16.6K |
|
3811
Information Services Group
III
$185M
| $88.2K | ﹤0.01% |
21,836
+4,859
| +29% | +$21.1K |
|
3812
CALL
Innoviz Technologies
INVZ
$135M
| $88.2K | ﹤0.01% |
65,300
| – | – |
|
3813
INNOVATE Corp
VATE
$114M
| $86.6K | ﹤0.01% |
12,355
+6,148
| +99% | +$54.2K |
|
3814
OppFi
OPFI
$770M
| $86.4K | ﹤0.01% |
34,558
+20,820
| +152% | +$70.7K |
|
|
BGFV
3815
DELISTED
Big 5 Sporting Goods
BGFV
| $86.1K | ﹤0.01% |
+24,465
| New | +$118K |
|
3816
CALL
Flux Power
FLUX
$12.6M
| $85.5K | ﹤0.01% |
+19,300
| New | +$89.6K |
|
3817
Fossil Group
FOSL
$239M
| $82.3K | ﹤0.01% |
80,685
+18,560
| +30% | +$20.7K |
|
3818
Aura Biosciences
AURA
$729M
| $82K | ﹤0.01% |
+10,447
| New | +$86.6K |
|
3819
Atea Pharmaceuticals
AVIR
$379M
| $81.4K | ﹤0.01% |
+20,153
| New | +$78.9K |
|
3820
Spruce Power Holding Corp
SPRU
$39.9M
| $81.1K | ﹤0.01% |
20,425
-25,285
| -55% | -$99.6K |
|
3821
Blink Charging
BLNK
$75.2M
| $80.7K | ﹤0.01% |
+26,811
| New | +$75.7K |
|
|
SYRS
3822
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $79.7K | ﹤0.01% |
+14,890
| New | +$103K |
|
|
AWH
3823
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $78.9K | ﹤0.01% |
25,438
+10,073
| +66% | +$43.5K |
|
|
LL
3824
DELISTED
LL Flooring Holdings, Inc.
LL
| $78.3K | ﹤0.01% |
+42,780
| New | +$103K |
|
3825
Nuvation Bio
NUVB
$2.24B
| $76.9K | ﹤0.01% |
21,138
-153,139
| -88% | -$294K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.